References
- EngelCBrunkhorstFMBoneHGEpidemiology of sepsis in Germany: results from a national prospective multicenter studyIntensive Care Med200733460661817323051
- GaieskiDFEdwardsJMKallanMJCarrBGBenchmarking the incidence and mortality of severe sepsis in the United StatesCrit Care Med20134151167117423442987
- RemickDGBolgosGCopelandSSiddiquiJRole of interleukin-6 in mortality from and physiologic response to sepsisInfect Immun20057352751275715845478
- PalluaNvon HeimburgDPathogenic role of interleukin-6 in the development of sepsis. Part I: study in a standardized contact burn murine modelCrit Care Med20033151490149412771623
- OpalSMDellingerRPVincentJLMasurHAngusDCThe next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*Crit Care Med20144271714172124717456
- BurasJAHolzmannBSitkovskyMAnimal models of sepsis: setting the stageNat Rev Drug Discov200541085486516224456
- HotchkissRSCoopersmithCMKarlIEPrevention of lymphocyte apoptosis – a potential treatment of sepsis?Clin Infect Dis200541suppl 7S465S46916237649
- MuenzerJTDavisCGDunneBSUnsingerJDunneWMHotchkissRSPneumonia after cecal ligation and puncture: a clinically relevant “two-hit” model of sepsisShock200626656557017117130
- MuenzerJTDavisCGChangKCharacterization and modulation of the immunosuppressive phase of sepsisInfect Immun20107841582159220100863
- GomezHGGonzalezSMLondonoJMImmunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study*Crit Care Med201442477178024365860
- OsuchowskiMFCraciunFWeixelbaumerKMDuffyERRemickDGSepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsisJ Immunol201218994648465623008446
- NovotnyARReimDAssfalgVMixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsisImmunobiology2012217661662122204813
- XiaoHWangSMiaoRKanWTRAIL is associated with impaired regulation of CD4+CD25- T cells by regulatory T cells in patients with rheumatoid arthritisJ Clin Immunol20113161112111921732015
- HayakawaYScrepantiVYagitaHNK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacyJ Immunol2004172112312914688317
- CollisonAFosterPSMattesJEmerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responsesClin Exp Pharmacol Physiol200936111049105319656161
- CziupkaKBusemannAParteckeLITumor necrosis factor-related apoptosis-inducing ligand (TRAIL) improves the innate immune response and enhances survival in murine polymicrobial sepsisCrit Care Med201038112169217420657274
- BeyerKPoetschkeCParteckeLITRAIL induces neutrophil apoptosis and dampens sepsis-induced organ injury in murine colon ascendens stent peritonitisPLoS One201496e9745124887152
- McGrathEEMarriottHMLawrieATNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammationJ Leukoc Biol201190585586521562052
- GurungPRaiDCondottaSABabcockJCBadovinacVPGriffithTSImmune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is TRAIL dependentJ Immunol201118752148215421788440
- SedgerLMGlaccumMBSchuhJCCharacterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient miceEur J Immunol20023282246225412209637
- MaierSTraegerTEntleutnerMCecal ligation and puncture versus colon ascendens stent peritonitis: two distinct animal models for polymicrobial sepsisShock200421650551115167678
- ZantlNUebeANeumannBEssential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsisInfect Immun1998665230023099573121
- UnsingerJKazamaHMcDonoughJSGriffithTSHotchkissRSFergusonTASepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanismJ Immunol2010184126766677220483771
- LehnertCWeiswangeMJeremiasITRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferationJ Immunol20149384021403125217163
- CondamineTKumarVRamachandranIRER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosisJ Clin Invest201412462626263924789911
- LaiDQinCShuQMyeloid-derived suppressor cells in sepsisBiomed Res Int2014201459865424995313
- AyalaAHerdonCDLehmanDLAyalaCAChaudryIHDifferential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediatorsBlood19968710426142758639785
- BusseMTraegerTPotschkeCDetrimental role for CD4+ T lymphocytes in murine diffuse peritonitis due to inhibition of local bacterial eliminationGut200857218819517965062
- CondottaSACabrera-PerezJBadovinacVPGriffithTST-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppressionCrit Rev Immunol2013331234023510024
- AnelABosqueANavalJApo2L/TRAIL and immune regulationFront Biosci2007122074208417127445